[
  {
    "ts": null,
    "headline": "Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025",
    "summary": "SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia. The Tour brings rugby fans’ dreams to life over a six-week period. For the first time in 12 years, The Lions squad, alongside an estimated 40,000 fans, will battle it out with the Wallabies,",
    "url": "https://finnhub.io/api/news?id=4588dbfb5e0bfdac2507027946fe484919be327768170cf9e07d3ebbfca3cb93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747314000,
      "headline": "Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025",
      "id": 134483927,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia. The Tour brings rugby fans’ dreams to life over a six-week period. For the first time in 12 years, The Lions squad, alongside an estimated 40,000 fans, will battle it out with the Wallabies,",
      "url": "https://finnhub.io/api/news?id=4588dbfb5e0bfdac2507027946fe484919be327768170cf9e07d3ebbfca3cb93"
    }
  },
  {
    "ts": null,
    "headline": "Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ResMed (NYSE:RMD) and the best and worst performers in the patient monitoring industry.",
    "url": "https://finnhub.io/api/news?id=8ca6bc9082b39fec03b95cdea27cb4998aaa694083e9fb549f9d90099bc8d4c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747280088,
      "headline": "Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest",
      "id": 134465834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ResMed (NYSE:RMD) and the best and worst performers in the patient monitoring industry.",
      "url": "https://finnhub.io/api/news?id=8ca6bc9082b39fec03b95cdea27cb4998aaa694083e9fb549f9d90099bc8d4c1"
    }
  }
]